An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.
about
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
An internally validated new cl ...... cinoma treated with sorafenib.
@en
An internally validated new cl ...... cinoma treated with sorafenib.
@nl
type
label
An internally validated new cl ...... cinoma treated with sorafenib.
@en
An internally validated new cl ...... cinoma treated with sorafenib.
@nl
prefLabel
An internally validated new cl ...... cinoma treated with sorafenib.
@en
An internally validated new cl ...... cinoma treated with sorafenib.
@nl
P2093
P2860
P1476
An internally validated new cl ...... rcinoma treated with sorafenib
@en
P2093
D Akhoundova
G Bruixola
J Aparicio
J Caballero
P2860
P2888
P304
P356
10.1007/S12094-017-1720-4
P577
2017-08-11T00:00:00Z